Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 16 | 13 | −3 |
| Shares | 116.7K | 64.3K | −52.5K (−44.9%) |
| Value | $164.7K | $94.9K | −$69.8K (−42.4%) |
New holders (1)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| National Bank of Canada | 313 | $198 | 0.00% |
Sold out (4)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Virtu Financial LLC | 24,825 | $35.0K |
| Schonfeld Strategic Advisors LLC | 22,600 | $31.9K |
| FMR LLC | 20 | $28 |
| First Manhattan Co | 10 | $14 |